Valuation Neurocrine Biosciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 13/03/2026 am IST			5-day change	1st Jan Change
127.78 ^USD	-1.36%		-1.43%	-9.91%

09/03	Neurocrine Biosciences, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 08:40 AM
04/03	Neurocrine Biosciences, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 11:50 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	8,080	11,482	12,946	13,820	14,141	12,824	-	-
Change	-	42.11%	12.74%	6.76%	2.32%	-9.31%	-	-
Enterprise Value (EV) ¹	7,704	10,363	11,397	12,005	11,598	9,845	9,099	7,072
Change	-	34.52%	9.97%	5.33%	-3.39%	-15.11%	-7.58%	-22.27%
P/E ratio	92.6x	76.6x	53.3x	41.5x	30.4x	21.6x	16x	12.4x
PBR	5.86x	6.75x	5.83x	5.24x	4.36x	3.16x	2.6x	2.12x
PEG	-	1.1x	0.9x	1.3x	0.7x	0.8x	0.5x	0.4x
Capitalization / Revenue	7.13x	7.71x	6.86x	5.87x	4.94x	3.72x	3.37x	3.06x
EV / Revenue	6.8x	6.96x	6.04x	5.1x	4.05x	2.86x	2.39x	1.69x
EV / EBITDA	58.9x	39.2x	42.4x	20.1x	17.9x	13.4x	9.55x	5.84x
EV / EBIT	75.2x	41.6x	45.4x	21x	18.7x	13.3x	9.08x	5.33x
EV / FCF	33x	32.1x	31.5x	21.5x	15.5x	12.3x	8.96x	5.89x
FCF Yield	3.03%	3.12%	3.17%	4.64%	6.46%	8.14%	11.2%	17%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.92	1.56	2.47	3.29	4.67	5.929	7.996	10.33
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,134	1,489	1,887	2,355	2,860	3,445	3,810	4,188
EBITDA ¹	130.7	264.1	268.7	597.6	649.2	734.9	952.6	1,212
EBIT ¹	102.5	249	250.9	570.5	619.1	738.4	1,002	1,327
Net income ¹	89.6	154.5	249.7	341.3	478.6	614.5	813.9	1,078
Net Debt ¹	-376.2	-1,119	-1,549	-1,816	-2,543	-2,979	-3,725	-5,752
Reference price ²	85.17	119.44	131.76	136.50	141.83	127.78	127.78	127.78
Nbr of stocks (in thousands)	94,867	96,134	98,252	1,01,247	99,706	1,00,363	-	-
Announcement Date	11/02/22	06/02/23	07/02/24	06/02/25	11/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NEUROCRINE BIOSCIENCES, INC.	21.55x	2.86x	13.4x	-.--%	1.28TCr
ELI LILLY AND COMPANY	28.72x	10.82x	21.74x	0.68%	87TCr
JOHNSON & JOHNSON	25.68x	5.98x	16.28x	2.19%	58TCr
ABBVIE INC.	24.62x	6.7x	13.46x	3.08%	40TCr
ROCHE HOLDING AG	17.19x	4.19x	10.36x	3.16%	32TCr
ASTRAZENECA PLC	24.12x	5.03x	13.93x	1.73%	30TCr
NOVARTIS AG	20.99x	5.66x	13.99x	2.86%	29TCr
MERCK & CO., INC.	27.09x	4.75x	14.85x	2.91%	29TCr
AMGEN INC.	24.74x	6.28x	11.18x	2.73%	20TCr
GILEAD SCIENCES, INC.	20.13x	6.12x	11.08x	2.24%	18TCr
Average	23.48x	5.84x	14.02x	2.16%	34.48TCr
Weighted average by Cap.	24.75x	6.92x	15.69x	2.1%